Aarti Drugs Q4 Results

  • BSE: 524348
  • NSE: AARTIDRUGS
  • ISIN: INE767A01016
  • Sector: Biotechnology & Drugs
BSE
492.651.40 (0.28%)
Volume5.11 K
Updated: Fri 24 May, 2024 | 15:28:20
NSE
492.40.80 (0.16%)
Volume64.38 K
Updated: Fri 24 May, 2024 | 15:58:03
Today: 487.05
496.65
52-Wk: 430.00
645.00

Q4 Results Highlights

  • Total Income
    ₹619.99 Cr.
    (-16.49%)
  • Operating Profit
    ₹72.23 Cr.
    (-10.86%)
  • Profit After Tax
    ₹47.37 Cr.
    (-15.54%)
  • Operating Margin
    11.65%
    (6.74%)
Note: Comparison is on YoY basis

Quarterly - Aarti Drugs Q4 Results

*All figures in crores except per share values
Fiscal PeriodMar 24Dec 23QoQ CompMar 23YoY Comp
Total Revenue 619.99605.942.32%742.41-16.49%
Selling/ General/ Admin Expenses Total 25.8725.551.25%25.461.61%
Depreciation/ Amortization 13.5812.667.27%12.508.60%
Other Operating Expenses Total 111.21105.025.89%107.903.07%
Total Operating Expense 547.76548.47-0.13%661.38-17.18%
Operating Income 72.2357.4725.68%81.03-10.86%
Net Income Before Taxes 64.1851.5524.50%73.28-12.42%
Net Income 47.3736.6729.18%56.09-15.54%
Diluted Normalized EPS 5.153.9929.07%6.06-15.04%

Recommended For You

    More Recommendations

    Trending Stocks

      Subscribe to Our Newsletter

      Get daily newsletters around different themes from livemint.

      Subscribe
      HomeMarketsPremiumFor youGet App